Search

6 results on this page

Claude Enters Protein Design

Claude Enters Protein Design

Claude is expanding into protein design, adding a scientific research capability to its existing AI portfolio. The update suggests potential use in computational biology and biotech workflows, though the article excerpt does not provide implementation or benchmark details.

The NeuronMedia12h ago#protein-design#scientific-ai
Shiyao's AI Drug Bet Needs Real Products

Shiyao's AI Drug Bet Needs Real Products

石藥創新上半年營收與淨利大幅增長,主要由巨石生物與AstraZeneca合作取得的4.2億美元首付款帶動,而非已上市藥品銷售。這項合作凸顯其AI多肽發現平台與LiquidGel長效遞送技術的價值,但公司仍需依靠ADC等候選藥物上市,才能從出售管線轉向銷售產品。

Page 1